MDMA effects on oxytocin in adults with mild autism
Treatments studied
Part of Mental health clinical trials.
This study tests whether the drug MDMA (commonly known as ecstasy) affects levels of oxytocin (a hormone linked to social bonding) in adults with mild autism compared to healthy volunteers. The goal is to see if MDMA might help with social challenges, but it's an early research study and not a treatment for autism.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 or older) with a confirmed diagnosis of autism spectrum disorder level 1 (mild autism).
- You should not have any significant heart problems, like heart failure, irregular heartbeat, or recent stroke.
- You should not have a history of major psychiatric conditions like major depression or schizophrenia.
- You should not have epilepsy or a history of seizures.
- You must not be pregnant or breastfeeding, and you should avoid heavy alcohol, tobacco, or illicit drug use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether oxytocin can help improve bone health in children and teens with autism spectrum disorder. It also checks safety by monitoring symptoms and doing blood tests and imaging.
This trial tests an experimental drug called DT402 to see if it can improve social and communication skills in adults with autism. You may join if you are between 18 and 65, have a confirmed autism diagnosis, and have noticeable social challenges.
This trial tests whether adding oxytocin nasal spray to standard behavioral therapy can help reduce challenging behaviors in children with autism and intellectual disability. It aims to see if the treatment is safe and practical.
This study tests if the antidepressant escitalopram can improve brain function in teenagers with autism. Participants will take the medicine and have brain scans (MRI) to see how it affects brain activity.
This study tests a marijuana-based compound (similar to CBD but not psychoactive) to see if it helps reduce anxiety in autistic adults. You would take a daily capsule and be monitored for 12 weeks.
This trial tests whether mild brain stimulation (TMS) over the temporoparietal junction can improve a social thinking skill called 'mentalizing' in adults with autism. You would have MRI scans, cognitive tasks, and several TMS sessions.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.